
Genmab Investor Relations Material
Latest events

Investor Update
Genmab
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Genmab
Access all reports
Segment Data
Access more data
Revenue by
Type
Royalties
Milestone revenue
Reimbursement revenue
Collaboration revenue
License revenue
Expenses by
Financials
Genmab, a biotechnology company, develops antibody therapeutics for the treatment of cancer and other diseases primarily in Europe.
Key slides for Genmab


Investor Update
Genmab


Q4 2024
Genmab
Latest articles
)
James Quincey: Coca-Cola Chairman and CEO
James Quincey has dedicated nearly three decades to The Coca-Cola Company, rising through the ranks to become CEO and Chairman of the company.
11 Mar 2025
)
PepsiCo: From Pepsi and Gatorade to Doritos and Lay's
PepsiCo has grown from a soda company into a global leader in food and beverages, with a portfolio of over 200 brands, including Pepsi, Lay's, and Gatorade.
11 Mar 2025
)
Bob Iger: Disney's Visionary CEO
Bob Iger is a legend in the entertainment industry, known for his visionary leadership and as one of the most influential CEOs in Disney's history.
10 Mar 2025
Ticker symbol
GMAB
Country
🇩🇰 Denmark